Home

kawasaki disease guidelines 2017, Efficacy of primary treatment with immunoglobulin ciclosporin for prevention of coronary artery in patients with Kawasaki disease predicted to be at increased of non-response to intravenous immunoglobulin (KAICA): a, Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki | Italian Journal of Pediatrics | Full Text